Status:

NOT_YET_RECRUITING

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

Lead Sponsor:

Qilu Pharmaceutical Co., Ltd.

Conditions:

Advanced Solid Tumor

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The goal of this clinical trial is to evaluate the safety and efficacy of QLP2117 in combination with QL2107 in Advanced Solid Tumor Patients.

Eligibility Criteria

Inclusion

  • Histological or cytological confirmation of recurrent or refractory advanced solid tumours, and have progressed on standard therapy, or are intolerable for available standard therapy, or there is no available standard therapy.
  • At least one measurable disease for expansion cohorts per Response Evaluation Criteria in Solid Tumours (RECIST) v1.1(phase Iba dose escalation only requires at least one assessable lesion)
  • Eastern Cooperative Oncology Group Performance Status of 0 or 1
  • Agree to provide archived tumor tissue samples of primary or metastatic lesions.
  • Have adequate organ function as described in the protocol.

Exclusion

  • Women who are pregnant or breastfeeding
  • HBsAg/HBcAb positive and HBV-DNA\>1000 copy/mL;HCV-Ab positive and detection of HCV-RNA suggested viral replication
  • Is currently participating and receiving study medication in another study within 4 week prior to the first dose of study treatment
  • Has an active autoimmune disease that has required systemic treatment in past 2 years.
  • Has an active infection requiring systemic therapy
  • Has received a live vaccine wihtin 30 days of planned start of study treatment
  • Known history of, or any evidence of interstitial lung disease

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06911827

Start Date

April 1 2025

End Date

December 1 2028

Last Update

April 9 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients | DecenTrialz